Efficacy Evaluation of Sabizabulin Monotherapy Versus Active Control for Treatment of ER+HER2- Metastatic Breast Cancer
Condition: Metastatic Breast Cancer Interventions: Drug: Sabizabulin; Drug: Exemestane monotherapy, exemestane plus everolimus, or selective estrogen receptor modulator Sponsor: Veru Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials